Chronic otorrhea and osteomyelitis of the external auditory canal by Achromobacter xylosoxidans: an uncommon diagnosis.


Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 20 11 2023
accepted: 08 01 2024
medline: 18 3 2024
pubmed: 17 2 2024
entrez: 17 2 2024
Statut: ppublish

Résumé

Achromobacter xylosoxidans is an emerging pathogen mainly associated with resistant nosocomial infections. This bacteria had been isolated in the ear together with other pathogens in cultures from patients with chronic otitis media, but it had never been reported as a cause of osteomyelitis of the external auditory canal. We present a unique case of a healthy 81-year-old woman who presented with left chronic otorrhea refractory to topical and oral antibiotic treatment. Otomicroscopy revealed an erythematous and exudative external auditory canal (EAC) with scant otorrhea. The tympanic membrane was intact, but an area of bone remodeling with a small cavity anterior and inferior to the bony tympanic frame was observed. Otic culture isolated multi-drug-resistant A. xylosoxidans, only sensitive to meropenem and cotrimoxazole. Temporal bone computed tomography showed an excavation of the floor of the EAC compatible with osteomyelitis. Targeted antibiotherapy for 12 weeks was conducted, with subsequent resolution of symptoms and no progression of the bone erosion. Atypical pathogens such as A. xylosoxidans can be the cause of chronic otitis externa. Early diagnosis and specific antibiotherapy can prevent the development of further complications, such as osteomyelitis. In these cases, otic cultures play an essential role to identify the causal germ. This is the first case of EAC osteomyelitis due to A. xylosoxidans reported to date.

Identifiants

pubmed: 38367073
doi: 10.1007/s00405-024-08465-8
pii: 10.1007/s00405-024-08465-8
pmc: PMC10942891
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2031-2035

Informations de copyright

© 2024. The Author(s).

Références

Pediatr Infect Dis J. 1988 Jan;7(1):26-34
pubmed: 2893333
Jpn J Microbiol. 1971 Sep;15(5):477-81
pubmed: 5316576
IDCases. 2021 Jun 29;25:e01211
pubmed: 34277350
Cytokine Growth Factor Rev. 2021 Jun;59:9-21
pubmed: 33551332
Eur J Intern Med. 2007 Sep;18(5):447
pubmed: 17693242
BMJ Case Rep. 2015 Sep 07;2015:
pubmed: 26347234
Infect Control Hosp Epidemiol. 1988 Feb;9(2):84-7
pubmed: 3278052
Am J Otolaryngol. 2021 Mar-Apr;42(2):102894
pubmed: 33429178
J Laryngol Otol. 1987 Mar;101(3):216-21
pubmed: 3106547
Am J Dis Child. 1991 Jun;145(6):599-600
pubmed: 1674638
J Med Microbiol. 2022 May;71(5):
pubmed: 35587447
IDCases. 2015 Jan 13;2(1):11-2
pubmed: 26793447
Otol Neurotol. 2018 Jun;39(5):597-601
pubmed: 29738387
Clin Infect Dis. 1993 Jan;16(1):176-8
pubmed: 8280199
Laryngoscope. 2020 Jul;130(7):1812-1816
pubmed: 31750969
Spine (Phila Pa 1976). 2014 Mar 15;39(6):E413-6
pubmed: 24384664
Laryngoscope. 2019 Apr;129(4):961-966
pubmed: 30549258
Rev Chilena Infectol. 2012 Aug;29(4):453-4
pubmed: 23096549
J Infect Chemother. 2012 Dec;18(6):915-8
pubmed: 22286410

Auteurs

Coloma Grau-van Laak (C)

PhD Program in Medicine and Surgery, Autonomous University of Madrid, Madrid, Spain. coloma.grau@estudiante.uam.es.
Department of Otolaryngology, La Paz University Hospital, Paseo de la Castellana, 261, 28046, Madrid, Spain. coloma.grau@estudiante.uam.es.
IdiPAZ Research Institute, Madrid, Spain. coloma.grau@estudiante.uam.es.

Carmen Ruiz-García (C)

PhD Program in Medicine and Surgery, Autonomous University of Madrid, Madrid, Spain.
Department of Otolaryngology, La Paz University Hospital, Paseo de la Castellana, 261, 28046, Madrid, Spain.
IdiPAZ Research Institute, Madrid, Spain.

Luis Lassaletta (L)

PhD Program in Medicine and Surgery, Autonomous University of Madrid, Madrid, Spain.
Department of Otolaryngology, La Paz University Hospital, Paseo de la Castellana, 261, 28046, Madrid, Spain.
IdiPAZ Research Institute, Madrid, Spain.
Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.

J Manuel Morales-Puebla (JM)

Department of Otolaryngology, La Paz University Hospital, Paseo de la Castellana, 261, 28046, Madrid, Spain.
IdiPAZ Research Institute, Madrid, Spain.
Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH